(Xenon Xe 129)


Drug updated on 11/15/2023

Dosage FormInhalation (oral; 1000 mL)
Drug ClassHyperpolarized contrast agents
Ongoing and Completed StudiesClinicalTrials.gov


  • For use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Xenoview (xenon Xe 129 hyperpolarized) Prescribing Information. 2022Polarean, Inc., Durham, NC

Systematic Reviews / Meta-Analyses